Galapagos NV (GLPG) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Galapagos NV (GLPG) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: June 8, 2023 (13:51)

Sector: Healthcare

The share price of Galapagos NV (GLPG) now

What analysts predict: $47.57
52-week High/Low: $58.67 / $36.16

50/200 Day Moving Average: $39.88 / $42.55

This figure corresponds to the Average Price over the previous 50/200 days. For Galapagos NV stocks, the 50-day moving average is the support level today.

For Galapagos NV stocks, the 200-day moving average is the support level today.

Are you interested in Galapagos NV stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Galapagos NV stock price in 2023, 2024, 2025, 2026, 2027. How much will one Galapagos NV share be worth in 2023 - 2027?

When should I take profit in Galapagos NV stock? When should I record a loss on Galapagos NV stock? What are analysts' forecasts for Galapagos NV stock? What is the future of Galapagos NV stock? We forecast Galapagos NV stock performance using neural networks based on historical data on Galapagos NV stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Galapagos NV stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Galapagos NV shares. This happens once a day.




Historical and forecast chart of Galapagos NV stock

The chart below shows the historical price of Galapagos NV stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Galapagos NV stock price can be found in the table below.

Long-term forecasts by years.

Galapagos NV daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 10 44.09 43.28 44.50 2.82
Jun 11 43.72 43.13 44.28 2.66
Jun 12 42.69 42.27 43.33 2.51
Jun 13 43.33 42.70 44.32 3.80
Jun 14 43.56 42.55 44.23 3.94
Jun 15 43.97 43.46 44.67 2.76
Jun 16 43.96 42.80 45.16 5.50
Jun 17 43.65 42.61 44.75 5.02
Jun 18 42.38 41.68 42.95 3.02
Jun 19 41.08 40.07 41.87 4.48
Jun 20 41.58 41.26 41.97 1.73
Jun 21 42.07 41.49 43.18 4.08
Jun 22 43.31 42.43 44.39 4.61
Jun 23 43.31 42.93 44.16 2.86
Jun 24 44.01 43.04 44.89 4.29
Jun 25 45.16 44.31 45.65 3.03
Jun 26 46.25 45.56 47.02 3.20
Jun 27 45.48 44.35 46.11 3.98
Jun 28 44.16 43.04 44.85 4.20
Jun 29 43.85 43.49 44.66 2.68
Jun 30 44.31 43.42 44.70 2.93
Jul 01 43.70 43.08 44.88 4.19
Jul 02 43.66 42.89 44.10 2.81
Jul 03 44.59 43.57 45.24 3.83
Jul 04 44.11 42.92 44.54 3.78
Jul 05 44.17 43.55 45.13 3.62
Jul 06 42.74 41.56 43.75 5.26
Jul 07 42.07 41.51 42.54 2.48
Jul 08 42.23 41.17 43.12 4.74
Jul 09 41.89 41.16 42.36 2.92

Galapagos NV Daily Price Targets


Galapagos NV Stock Forecast 06-10-2023.

Forecast target price for 06-10-2023: $44.09.
Positive dynamics for Galapagos NV shares will prevail with possible volatility of 2.739%.
Pessimistic target level: 43.28
Optimistic target level: 44.50

Galapagos NV Stock Forecast 06-11-2023.

Forecast target price for 06-11-2023: $43.72.
Negative dynamics for Galapagos NV shares will prevail with possible volatility of 2.591%.
Pessimistic target level: 43.13
Optimistic target level: 44.28

Galapagos NV Stock Forecast 06-12-2023.

Forecast target price for 06-12-2023: $42.69.
Negative dynamics for Galapagos NV shares will prevail with possible volatility of 2.448%.
Pessimistic target level: 42.27
Optimistic target level: 43.33

Galapagos NV Stock Forecast 06-13-2023.

Forecast target price for 06-13-2023: $43.33.
Positive dynamics for Galapagos NV shares will prevail with possible volatility of 3.662%.
Pessimistic target level: 42.70
Optimistic target level: 44.32

Galapagos NV Stock Forecast 06-14-2023.

Forecast target price for 06-14-2023: $43.56.
Positive dynamics for Galapagos NV shares will prevail with possible volatility of 3.792%.
Pessimistic target level: 42.55
Optimistic target level: 44.23

Galapagos NV Stock Forecast 06-15-2023.

Forecast target price for 06-15-2023: $43.97.
Positive dynamics for Galapagos NV shares will prevail with possible volatility of 2.688%.
Pessimistic target level: 43.46
Optimistic target level: 44.67

GLPG (GLPG) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jul. 45.26 43.02 48.31 10.94
Aug. 42.29 40.81 47.64 14.35
Sep. 43.65 42.18 47.77 11.70
Oct. 42.95 37.52 46.73 19.71
Nov. 44.94 41.99 50.12 16.21
Dec. 50.84 47.10 57.27 17.76

Galapagos NV forecast for this year


Galapagos NV Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $45.264. Pessimistic: $43.02. Optimistic: $48.31


Galapagos NV Stock Prediction for Aug 2023

An downtrend is forecast for this month with an optimal target price of $42.2947. Pessimistic: $40.81. Optimistic: $47.64


Galapagos NV Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $43.6481. Pessimistic: $42.18. Optimistic: $47.77


Galapagos NV Stock Prediction for Oct 2023

An downtrend is forecast for this month with an optimal target price of $42.9497. Pessimistic: $37.52. Optimistic: $46.73


Galapagos NV Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $44.9426. Pessimistic: $41.99. Optimistic: $50.12


Galapagos NV Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $50.8391. Pessimistic: $47.10. Optimistic: $57.27



Galapagos NV (GLPG) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 58.16 53.13 60.21 11.75
Feb 57.69 53.08 65.08 18.44
Mar 57.69 51.05 62.68 18.56
Apr 62.03 58.56 66.40 11.81
May 55.38 49.27 61.50 19.88
Jun 56.18 50.61 61.03 17.08
Jul 60.86 57.45 66.11 13.11
Aug 60.27 54.77 64.61 15.22
Sep 69.24 62.26 73.56 15.36
Oct 64.48 59.21 69.43 14.71
Nov 67.88 63.86 74.50 14.29
Dec 75.27 67.32 81.17 17.06

Galapagos NV (GLPG) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 84.66 76.40 90.08 15.19
Feb 80.59 71.70 83.95 14.59
Mar 69.63 62.17 78.55 20.85
Apr 71.19 64.47 73.59 12.38
May 64.59 60.66 71.61 15.30
Jun 74.09 67.46 78.12 13.66
Jul 72.08 64.93 80.84 19.69
Aug 68.50 59.84 76.50 21.78
Sep 63.13 59.09 65.46 9.72
Oct 55.66 49.78 59.84 16.82
Nov 53.16 51.38 56.57 9.17
Dec 46.95 43.27 48.83 11.38

Galapagos NV (GLPG) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 45.83 44.07 48.83 9.76
Feb 51.11 45.38 57.65 21.28
Mar 56.42 51.73 61.30 15.61
Apr 57.87 55.55 62.13 10.58
May 65.37 60.24 70.80 14.92
Jun 65.05 62.24 72.86 14.57
Jul 70.15 66.11 78.68 15.98
Aug 80.14 75.40 86.55 12.89
Sep 76.94 70.04 79.52 11.92
Oct 72.51 65.08 78.42 17.01
Nov 68.10 65.37 73.22 10.71
Dec 72.56 66.88 76.98 13.12

Galapagos NV (GLPG) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 67.22 62.60 70.02 10.60
Feb 74.43 70.74 80.86 12.52
Mar 78.48 69.44 82.62 15.96
Apr 90.78 82.94 99.06 16.28
May 101.97 95.77 113.88 15.90
Jun 104.25 95.08 107.76 11.76
Jul 109.92 106.41 123.64 13.94
Aug 109.57 99.93 118.51 15.68
Sep 106.24 99.27 115.25 13.86
Oct 95.19 89.40 103.11 13.29
Nov 88.80 82.12 94.48 13.08
Dec 94.76 87.03 98.86 11.96

Galapagos NV information and performance

Galapagos NV, a clinical stage biotechnology company, discovers, develops and markets various small molecule drugs. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for rheumatoid arthritis, Crohn’s disease, ulcerative colitis, small bowel CD, fistulizing CD, Sjögren’s syndrome, ankylosing spondylitis, psoriatic arthritis, cutaneous lupus erythematosus, membranous nephropathy lupus and uveitis.

Galapagos NV Address

GEN DE WITTELAAN L11 A3, 2800 MECHELEN, BE

Market Capitalization: 2 776 904 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -182 347 008 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.91

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 20.54
Quarterly Revenue Growth YOY: 0.312
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 81.3

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.184

Enterprise Value (EV) /Revenue

EV To EBITDA: -28.91

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 65897000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.